Filing Flows › Teladoc Health (TDOC) › Q4 2025
Teladoc Health (TDOC) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Feb 26, 2026
Teladoc Health (TDOC) reported revenue of $642M for the fourth quarter 2025 (Q4 2025), +0.3% from a year earlier and +3% from the quarter before. Operating margin was -5.6%, net loss $25.1M (3.9% of revenue).
Teladoc Health, Q4 2025: revenue $642M (+0.3% year over year), operating margin -5.6%, net loss $25.1M, operating cash flow $87.7M. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $642M | +3% | +0.3% |
| Operating profit | −$36.0M | — | — |
| Net earnings | −$25.1M | — | — |
| Operating cash flow | $87.7M | -12% | +2% |
| Free cash flow | $85.1M | -12% | +7% |
What changed
Revenue was $642.3M in Q4 2025, roughly flat year over year and up 3% from the previous quarter.
Operating costs exceeded revenue by $36.0M, an operating margin of -5.6%. Total costs fell 2% while revenue was flat. The quarter ended with a net loss of $25.1M, narrower than the previous quarter's $49.5M loss.
Operating cash flow was $87.7M (up 2% year over year). Non-cash charges added back $15.9M of share-based compensation. Working capital and other items added $97.0M. Capital expenditures of $2.6M left free cash flow of $85.1M.
Questions
What was Teladoc Health's revenue in the fourth quarter 2025?
Teladoc Health (TDOC) reported revenue of $642M for the fourth quarter 2025 (Q4 2025), +0.3% from a year earlier and +3% from the quarter before.
Was Teladoc Health profitable in the fourth quarter 2025?
Operating loss was $36.0M (-5.6% of revenue) and net loss $25.1M.
Source: Teladoc Health 10-K on SEC EDGAR.